NATCOPHARM Intraday Analysis...

NATCOPHARM Share Price

Open 602.75 Change Price %
High 602.80 1 Day -2.80 -0.47
Low 592.00 1 Week -10.00 -1.66
Close 593.80 1 Month 10.15 1.74
Volume 119274 1 Year 95.00 19.05
52 Week High 702.65
52 Week Low 390.00
NATCOPHARM Important Levels
Resistance 2 603.81
Resistance 1 599.69
Pivot 596.20
Support 1 587.91
Support 2 583.79
NSE INDIA Most Active Stocks
ADANIPOWER 31.80 -1.40%
UNITECH 4.70 0.00%
FEDERALBNK 69.20 -0.93%
SBIN 255.60 -1.35%
NATIONALUM 69.25 12.15%
TATAPOWER 74.30 -1.20%
HCC 39.45 0.90%
HCC 39.45 0.90%
VISESHINFO 0.35 16.67%
SUNPHARMA 664.00 -5.97%
More..
NSE INDIA Top Gainers Stocks
FARMAXIND 0.15 50.00%
NBIFIN 270.00 25.00%
PARASPETRO 0.25 25.00%
VIJIFIN 16.20 20.00%
ARCHIES 27.60 20.00%
KARMAENG 54.70 19.96%
VISESHINFO 0.35 16.67%
AUSTRAL 0.35 16.67%
SUJANAUNI 2.15 16.22%
ORICONENT 53.80 14.59%
More..
NSE INDIA Top Losers Stocks
BIRLACOT 0.05 -50.00%
RASOYPR 0.15 -25.00%
KSERASERA 0.15 -25.00%
PRADIP 1.90 -19.15%
FCSSOFT 0.25 -16.67%
RELIGARE 244.95 -8.69%
SHYAMTEL 35.40 -7.93%
VASWANI 9.30 -7.92%
BARTRONICS 16.50 -7.30%
LOTUSEYE 27.70 -6.73%
More..

Natco Pharma Limited (NSE: NATCOPHARM)

NATCOPHARM Technical Analysis 1.5
As on 7th Dec 2016 NATCOPHARM Share Price closed @ 593.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 547.94 & Sell for SHORT-TERM with Stoploss of 604.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
NATCOPHARM Target for December
1st Target up-side 705.72
2nd Target up-side 777.15
3rd Target up-side 848.58
1st Target down-side 501.89
2nd Target down-side 430.45
3rd Target down-side 359.02
NATCOPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 47.14 Sideways
MFI (14) MFI is 56.90 Sideways
CCI (20) CCI is -44.94 Sideways
WILLIAM %R (14) William %R is -67.28 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 680.89
10 Day Avg Volume Traded -45.63 % Less then 10 Day Average Volume
NATCOPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NATCOPHARM Address
NATCOPHARM
N/A
NATCOPHARM Latest News
Natco Pharma - Natco receives Generic Sofosbuvir (Sovaldi) approval for India   Moneycontrol.com   - 12th Mar 15
NATCO Pharma stock rises most on US court ruling   Business Today   - 11th Mar 15
Buy Natco Pharma; target of Rs 1920: ICICIdirect   Moneycontrol.com   - 11th Mar 15
UPDATE 1-India's Natco Pharma ties up with Gilead on hepatitis C drugs   Reuters   - 02nd Mar 15
Natco Pharma - Q3 results on Feb 11, 2015   Moneycontrol.com   - 30th Jan 15
Natco Pharma dips on preferential share allotment at discount   Business Standard   - 17th Dec 14
Natco Pharma CFO passes away   Hindu Business Line   - 23rd Oct 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir.)   JD Supra (press release)   - 25th Jul 14
Gilead Sciences, Inc. v. Natco Pharma Limited   Lexology (registration)   - 08th May 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)   Patent Docs   - 29th Apr 14
Interactive Technical Analysis Chart Natco Pharma Limited ( NATCOPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Natco Pharma Limited
NATCOPHARM Business Profile
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,439.26 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director. It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.